Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

A novel antihuman C3d monoclonal antibody with specificity to the C3d complement split product

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cryopreservation of peripheral blood mononuclear cells for use in proliferation assays: First step towards potency assays

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Efficient evaluation of humoral immune responses by the use of serum pools

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Circulating Ficolin-2 and Ficolin-3 Form Heterocomplexes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The complement component C3 and the cleavage products of C3b/iC3b, C3c and C3d are used as biomarkers in clinical diagnostics. Currently, no specific antibodies are able to differentiate C3d from other fragments, although such a distinction could be very valuable considering that they may reflect different pathophysiological mechanisms. We have developed a rat antihuman C3d monoclonal antibody with specificity to the end sequence of the N-terminal region of C3d. The antibody can therefore only bind to C3d when it manifests itself as the final end product of cleaved C3. We believe that this specificity is it first of its kind, and predicts that it can be used as a detection tool in several immunological methods with great value in diagnostics.

Original languageEnglish
JournalJournal of Immunological Methods
Volume444
Pages (from-to)51-55
Number of pages5
ISSN0022-1759
DOIs
Publication statusPublished - May 2017

    Research areas

  • Animals, Antibodies, Monoclonal, Antibody Specificity, Binding Sites, Antibody, Complement Activation, Complement C3d, Enzyme-Linked Immunosorbent Assay, Humans, Immunization, Injections, Subcutaneous, Protein Binding, Protein Interaction Domains and Motifs, Rats, Sprague-Dawley, Journal Article

ID: 51598829